High Content Imaging of Barrett’s-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions

Sinead M. Phipps1, Catherine E. Garry1, Sepehr Kamal2, James D. Johnson2, John Gilmer3, Aideen Long1, Dermot Kelleher1,2,4,5, Shane P. Duggan2,4,5
1Department of Clinical Medicine, Trinity Translational Medicine Institute, Trinity College, Dublin, Ireland
2Life Science Institute, University of British Columbia, Vancouver, British Columbia, Canada
3School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Ireland
4Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
5Centre for Complement and Inflammation Research, Imperial College London, London, United Kingdom

Tài liệu tham khảo

Otterstatter, 2012, Esophageal cancer in Canada: trends according to morphology and anatomical location, Can J Gastroenterol, 26, 723, 10.1155/2012/649108 Thrift, 2012, The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends, Ann Oncol, 23, 3155, 10.1093/annonc/mds181 Nguyen, 2017, The annual risk of esophageal adenocarcinoma does not decrease over time in patients with Barrett's esophagus, Am J Gastroenterol, 112, 1049, 10.1038/ajg.2017.18 Jemal, 2010, Cancer statistics, 2010, CA Cancer J Clin, 60, 277, 10.3322/caac.20073 Wang, 2011, Residual embryonic cells as precursors of a Barrett's-like metaplasia, Cell, 145, 1023, 10.1016/j.cell.2011.05.026 Yamamoto, 2016, Mutational spectrum of Barrett's stem cells suggests paths to initiation of a precancerous lesion, Nat Commun, 7, 10380, 10.1038/ncomms10380 Jiang, 2017, Transitional basal cells at the squamous-columnar junction generate Barrett's oesophagus, Nature, 550, 529, 10.1038/nature24269 Liu, 2019, Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer, Cancer Lett, 458, 21, 10.1016/j.canlet.2019.05.018 Que, 2019, Pathogenesis and cells of origin of Barrett's esophagus, Gastroenterology, 157, 349, 10.1053/j.gastro.2019.03.072 Agoston, 2018, Columnar-lined esophagus develops via wound repair in a surgical model of reflux esophagitis, Cell Mol Gastroenterol Hepatol, 6, 389, 10.1016/j.jcmgh.2018.06.007 Wang, 2010, Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia, Gastroenterology, 138, 1810, 10.1053/j.gastro.2010.01.048 Zhang, 2019, Acidic bile salts induce epithelial to mesenchymal transition via VEGF signaling in non-neoplastic Barrett's cells, Gastroenterology, 156, 130, 10.1053/j.gastro.2018.09.046 Wilson, 2008, Prognostic significance of lymph node metastases and ratio in esophageal cancer, J Surg Res, 146, 11, 10.1016/j.jss.2007.07.028 Aurello, 2006, Comparison between site N-category and number N-category for nodal staging in carcinoma of the gastroesophageal junction: our experience and literature review, Am Surg, 72, 118, 10.1177/000313480607200204 Wang, 2004, Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors, Cancer Res, 64, 8585, 10.1158/0008-5472.CAN-04-1136 Klein, 2009, Parallel progression of primary tumours and metastases, Nat Rev Cancer, 9, 302, 10.1038/nrc2627 Klein, 2009, Lessons from an aggressive cancer: evolutionary dynamics in esophageal carcinoma, Cancer Res, 69, 5285, 10.1158/0008-5472.CAN-08-4586 Yachida, 2010, Distant metastasis occurs late during the genetic evolution of pancreatic cancer, Nature, 467, 1114, 10.1038/nature09515 Rorth, 2011, Whence directionality: guidance mechanisms in solitary and collective cell migration, Dev Cell, 20, 9, 10.1016/j.devcel.2010.12.014 Liu, 2015, Confinement and low adhesion induce fast amoeboid migration of slow mesenchymal cells, Cell, 160, 659, 10.1016/j.cell.2015.01.007 Wolf, 2003, Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis, J Cell Biol, 160, 267, 10.1083/jcb.200209006 Paul, 2017, Cancer cell motility: lessons from migration in confined spaces, Nat Rev Cancer, 17, 131, 10.1038/nrc.2016.123 Pankova, 2010, The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells, Cell Mol Life Sci, 67, 63, 10.1007/s00018-009-0132-1 Benoit, 2012, Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells, J Immunol, 188, 5682, 10.4049/jimmunol.1103760 Clark, 2015, Modes of cancer cell invasion and the role of the microenvironment, Curr Opin Cell Biol, 36, 13, 10.1016/j.ceb.2015.06.004 Rohani, 2019, Acidification of tumor at stromal boundaries drives transcriptome alterations associated with aggressive phenotypes, Cancer Res, 79, 1952, 10.1158/0008-5472.CAN-18-1604 Brisson, 2012, pH regulators in invadosomal functioning: proton delivery for matrix tasting, Eur J Cell Biol, 91, 847, 10.1016/j.ejcb.2012.04.004 Paradise, 2013, Directional cell migration in an extracellular pH gradient: a model study with an engineered cell line and primary microvascular endothelial cells, Exp Cell Res, 319, 487, 10.1016/j.yexcr.2012.11.006 Robey, 2009, Bicarbonate increases tumor pH and inhibits spontaneous metastases, Cancer Res, 69, 2260, 10.1158/0008-5472.CAN-07-5575 Duggan, 2018, siRNA library screening identifies a druggable immune-signature driving esophageal adenocarcinoma cell growth, Cell Mol Gastroenterol Hepatol, 5, 569, 10.1016/j.jcmgh.2018.01.012 Duggan, 2006, Low pH induces co-ordinate regulation of gene expression in oesophageal cells, Carcinogenesis, 27, 319, 10.1093/carcin/bgi211 Duggan, 2016, The characterization of an intestine-like genomic signature maintained during Barrett's-associated adenocarcinogenesis reveals an NR5A2-mediated promotion of cancer cell survival, Sci Rep, 6, 32638, 10.1038/srep32638 Dubiel, 2015, Diversity of COP9 signalosome structures and functional consequences, FEBS Lett, 589, 2507, 10.1016/j.febslet.2015.06.007 Chamovitz, 2009, Revisiting the COP9 signalosome as a transcriptional regulator, EMBO Rep, 10, 352, 10.1038/embor.2009.33 Damsky, 2011, Beta-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas, Cancer Cell, 20, 741, 10.1016/j.ccr.2011.10.030 Qi, 2016, New Wnt/beta-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals, Gut, 65, 1690, 10.1136/gutjnl-2014-307900 Bian, 2000, Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus, Am J Clin Pathol, 114, 583, 10.1309/3QLC-5MF1-JYXU-A5XX Beavon, 2000, The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation, Eur J Cancer, 36, 1607, 10.1016/S0959-8049(00)00158-1 Nakamura, 2005, Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas, J Pathol, 205, 349, 10.1002/path.1718 Aye, 2015, Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies, Oncogene, 34, 2011, 10.1038/onc.2014.155 Foskolou, 2017, Ribonucleotide reductase requires subunit switching in hypoxia to maintain DNA replication, Mol Cell, 66, 206, 10.1016/j.molcel.2017.03.005 Comaills, 2016, Genomic instability is induced by persistent proliferation of cells undergoing epithelial-to-mesenchymal transition, Cell Rep, 17, 2632, 10.1016/j.celrep.2016.11.022 Baron, 2004, Fatty acid synthase: a metabolic oncogene in prostate cancer?, J Cell Biochem, 91, 47, 10.1002/jcb.10708 Warburg, 1956, On respiratory impairment in cancer cells, Science, 124, 269, 10.1126/science.124.3215.269 Warburg, 1956, On the origin of cancer cells, Science, 123, 309, 10.1126/science.123.3191.309 Burbridge, 1999, The effect of extracellular pH on angiogenesis in vitro, Angiogenesis, 3, 281, 10.1023/A:1009092511894 Tsuge, 2011, CSN1 inhibits c-Jun phosphorylation and down-regulates ectopic expression of JNK1, Protein Cell, 2, 423, 10.1007/s13238-011-1043-0 Tian, 2014, Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma, Hepatology, 59, 1459, 10.1002/hep.26929